PARECOXIB(Dynastat ®)

Clinical Indication

Inflammatory pain associated with cancer or other palliative conditions

Date of classification

November 2019

Review date

November 2019

Amber FULL SCA

Drugs which would initially be prescribed by a hospital specialist and then by a GP where full agreement to share the care of each specific patient has been reached under a LMSG Shared Care Agreement (SCA). Specific patient monitoring or intervention required.